United States Biotechnology & Medical Research

SAB Biotherapeutics Inc (SABS)

Track

SAB Biotherapeutics Inc has recorded no insider trading activity within the past ninety days. The most recent transactions occurred in late 2023, when key executives including the Chief Executive Officer and Chief Financial Officer acquired company shares. These historical purchases represent the final documented movements by corporate insiders.
Ticker: SABS Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for SAB Biotherapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.7
Sullivan Eddie Joe Chief Executive Officer Executive Director
Transaction date
Purchase
Price
433.50
Quantity 2,576 -13.7%
Value US$4,878,408
0.5
King Michael CHIEF FINANCIAL OFFICER Officer
Transaction date
Purchase
Price
351.91
Quantity 28,720 -31.8%
Value US$4,137,854
2.4
Reich Samuel J Executive Chairman Executive Director
Transaction date
Purchase
Price
457.82
Quantity 58,949 -41.8%
Value US$1,980,295
2.9
HAMILTON CHRISTINE E Non-Executive Director Large shareholder
Transaction date
Purchase
Price
0.73
Quantity 10,000 +0.2%
Value US$7,297
2.7
Sullivan Eddie Joe CHIEF EXECUTIVE OFFICER Executive Director Large shareholder
Transaction date
Purchase
Price
0.74
Quantity 14,000 +0.3%
Value US$10,315
2.3
Beyer Russell P Chief Financial Officer Officer
Transaction date
Sale
Price
7.90
Quantity 278 -100.0%
Value US$2,196
2.4
Reich Samuel J CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
10.11
Quantity 1,000 +inf%
Value US$10,110
2.3
Katz Ilan Non-Executive Director Large shareholder
Transaction date
Purchase
Price
10.11
Quantity 500 +50.0%
Value US$5,052
2.3
Katz Ilan Non-Executive Director Large shareholder
Transaction date
Purchase
Price
10.09
Quantity 1,000 +inf%
Value US$10,090
0.5
Spragens Jeffrey G Non-Executive Director
Transaction date
Purchase
Price
10.07
Quantity 13,000 +inf%
Value US$130,910
1.7
Big Cypress Holdings LLC CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
10.00
Quantity 417,200 +15.9%
Value US$4,172,000
2.3
Katz Ilan Non-Executive Director Large shareholder
Transaction date
Purchase
Price
10.00
Quantity 417,200 +15.9%
Value US$4,172,000
2.4
Reich Samuel J CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
10.00
Quantity 417,200 +15.9%
Value US$4,172,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-12-08 2023-12-07 B Purchase
2.7
Sullivan Eddie Joe

Chief Executive Officer

Executive Director
2,576 -13.7%
433.50
US$4,878,408 		2,576 -13.7% 433.50 US$4,878,408
2023-11-30 2023-11-30 B Purchase
0.5
King Michael

CHIEF FINANCIAL OFFICER

Officer
28,720 -31.8%
351.91
US$4,137,854 		28,720 -31.8% 351.91 US$4,137,854
2023-11-30 2023-11-29 B Purchase
2.4
Reich Samuel J

Executive Chairman

Executive Director
58,949 -41.8%
457.82
US$1,980,295 		58,949 -41.8% 457.82 US$1,980,295
2022-09-14 2022-09-13 B Purchase
2.9
HAMILTON CHRISTINE E
Non-Executive Director Large shareholder
10,000 +0.2%
0.73
US$7,297 		10,000 +0.2% 0.73 US$7,297
2022-09-08 2022-09-07 B Purchase
2.7
Sullivan Eddie Joe

CHIEF EXECUTIVE OFFICER

Executive Director Large shareholder
14,000 +0.3%
0.74
US$10,315 		14,000 +0.3% 0.74 US$10,315
2021-11-16 2021-10-26 S Sale
2.3
Beyer Russell P

Chief Financial Officer

Officer
278 -100.0%
7.90
US$2,196 		278 -100.0% 7.90 US$2,196
2021-10-15 2021-10-14 B Purchase
2.4
Reich Samuel J

CEO and CFO

Executive Director Large shareholder
1,000 +inf%
10.11
US$10,110 		1,000 +inf% 10.11 US$10,110
2021-10-15 2021-10-13 B Purchase
2.3
Katz Ilan
Non-Executive Director Large shareholder
500 +50.0%
10.11
US$5,052 		500 +50.0% 10.11 US$5,052
2021-10-05 2021-10-01 B Purchase
2.3
Katz Ilan
Non-Executive Director Large shareholder
1,000 +inf%
10.09
US$10,090 		1,000 +inf% 10.09 US$10,090
2021-10-05 2021-10-01 B Purchase
0.5
Spragens Jeffrey G
Non-Executive Director
13,000 +inf%
10.07
US$130,910 		13,000 +inf% 10.07 US$130,910
2021-01-14 2021-01-14 B Purchase
1.7
Big Cypress Holdings LLC

CEO and CFO

Executive Director Large shareholder
417,200 +15.9%
10.00
US$4,172,000 		417,200 +15.9% 10.00 US$4,172,000
2021-01-14 2021-01-14 B Purchase
2.3
Katz Ilan
Non-Executive Director Large shareholder
417,200 +15.9%
10.00
US$4,172,000 		417,200 +15.9% 10.00 US$4,172,000
2021-01-14 2021-01-14 B Purchase
2.4
Reich Samuel J

CEO and CFO

Executive Director Large shareholder
417,200 +15.9%
10.00
US$4,172,000 		417,200 +15.9% 10.00 US$4,172,000
Explore more

More insider trading research around SAB Biotherapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America